Follow-up Study to Evaluate Investigational Drug in Patients with Epilepsy

What we are studying

The purpose of this trial is to see how safe and effective the investigational medication is during long term use in reducing the frequency of seizures in patients who have partial onset seizures or generalized seizures.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 16+

Eligibility Criteria

  • 16 years of age and older
  • Subject completed Treatment Period of N01358 or Evaluation Period of N01258

What is involved

  • Usual treatments and investigational study medicine

Compensation

For your participation, you will be paid $50.00 for each completed visit until the end of the study.

Contact Information

Study Coordinator
Sara Vaughan
Email
svaughan@wakehealth.edu
Phone
336-716-8694

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.